Journal of Medical Physics
 Home | Search | Ahead of print | Current Issue | Archives | Instructions | Subscription | Login  The official journal of Association of Medical Physicists of India      
 Users online: 363  Home  EMail this page Print this page Decrease font size Default font size Increase font size 
ORIGINAL ARTICLE
Year : 2007  |  Volume : 32  |  Issue : 2  |  Page : 68-72

Clinical significance of cumulative biological effective dose and overall treatment time in the treatment of carcinoma cervix


Department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India

Correspondence Address:
Abhijit Mandal
Department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi - 221 005, Uttar Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-6203.33244

Rights and Permissions

The purpose of this retrospective study is to report the radiotherapy treatment response of, and complications in, patients with cervical cancer on the basis of cumulative biologic effective dose (BED) and overall treatment time (OTT). Sixty-four (stage II - 35/64; stage III - 29/64) patients of cervical cancer were treated with combination of external beam radiotherapy (EBRT) and low dose rate intracavitary brachytherapy (ICBT). The cumulative BED was calculated at Point A (BED 10 ); and bladder, rectal reference points (BED 2.5 ) using the linear-quadratic BED equations. The local control (LC) rate and 5-year disease-free survival (DFS) rate in patients of stage II were comparable for BED 10 <84.5 and BED 10 >84.5 but were much higher for BED 10 >84.5 than BED 10 <84.5 ( P < 0.01) in stage III patients. In the stage II patients, The LC rate and 5-year DFS rate were comparable for OTT <50 days and for OTT >50 days but were much higher in stage III patients with OTT <50 than OTT >50 days ( P < 0.001). It was also observed that patients who received BED 2.5 <105 had lesser rectal ( P < 0.001) and bladder complications than BED 2.5 >105. Higher rectal complication-free survival (CFS R ) rate, bladder complication-free survival (CFS B ) rate and all-type late complication-free survival rate were observed in patients who received BED 2.5 <105 than BED 2.5 >105. A balanced, optimal and justified radiotherapy treatment schedule to deliver higher BED 10 (>84.5) and lower BED 2.5 (<105) in lesser OTT (<50 days) is essential in carcinoma cervix to expect a better treatment outcome in all respects.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed5727    
    Printed141    
    Emailed2    
    PDF Downloaded484    
    Comments [Add]    
    Cited by others 3    

Recommend this journal